NC
CRL icon

Nicholas Company’s Charles River Laboratories CRL Stock Holding History

Nicholas Company’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Sell
71,895
-45
-0.1% -$8.01K 0.3% 73
2026
Q1 		$12.4M Buy
+71,940
New +$13.3M 0.24% 87
2025
Q3 		– Sell
-825
Closed -$125K – 218
2025
Q2 		$125K Sell
825
-68,621
-99% -$9.15M ﹤0.01% 216
2025
Q1 		$10.5M Hold
69,446
– – 0.18% 117
2024
Q4 		$12.8M Hold
69,446
– – 0.21% 109
2024
Q3 		$13.7M Sell
69,446
-1,235
-2% -$257K 0.22% 106
2024
Q2 		$14.6M Hold
70,681
– – 0.24% 104
2024
Q1 		$19.2M Hold
70,681
– – 0.32% 91
2023
Q4 		$16.7M Buy
70,681
+10,695
+18% +$2.1M 0.3% 94
2023
Q3 		$11.8M Hold
59,986
– – 0.24% 101
2023
Q2 		$12.6M Hold
59,986
– – 0.24% 100
2023
Q1 		$12.1M Buy
59,986
+10,275
+21% +$2.33M 0.25% 103
2022
Q4 		$10.8M Sell
49,711
-1,040
-2% -$227K 0.23% 106
2022
Q3 		$9.99M Hold
50,751
– – 0.23% 107
2022
Q2 		$10.9M Sell
50,751
-25
-0% -$6.11K 0.24% 104
2022
Q1 		$14.4M Sell
50,776
-904
-2% -$279K 0.26% 103
2021
Q4 		$19.5M Sell
51,680
-15
-0% -$5.83K 0.32% 87
2021
Q3 		$21.3M Sell
51,695
-8,860
-15% -$3.68M 0.38% 73
2021
Q2 		$22.4M Hold
60,555
– – 0.39% 71
2021
Q1 		$17.6M Sell
60,555
-495
-0.8% -$138K 0.33% 85
2020
Q4 		$15.3M Buy
61,050
+65
+0.1% +$15.5K 0.29% 99
2020
Q3 		$13.8M Buy
+60,985
New +$12.7M 0.29% 98

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Nicholas Company's CRL Position: Q2 2026 in Review

Nicholas Company reduced its Charles River Laboratories (CRL) stake by 0.06% in Q2 2026, selling an estimated $8.01K and leaving 71,895 shares worth $16.3M. The position accounts for 0.3% of the portfolio, ranked #73.

Nicholas Company first reported a position in CRL in Q3 2020 and has held it in 22 quarters since. The position peaked at $22.4M in Q2 2021. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Nicholas Company held 71,895 shares of Charles River Laboratories worth $16.3M as of Q2 2026.
  • Nicholas Company sold 45 Charles River Laboratories shares in Q2 2026, an estimated $8.01K.
  • Charles River Laboratories made up 0.3% of Nicholas Company's portfolio in Q2 2026, its #73 holding.
  • Nicholas Company first reported a position in Charles River Laboratories in Q3 2020 and has held it in 22 quarters since.
  • Nicholas Company's Charles River Laboratories position peaked at $22.4M in Q2 2021.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.